My 3 Favorite Stocks to Buy Right Now

As the calendar edges closer to year‑end, savvy investors are asking: which stocks deserve a spot in your portfolio? According to analyst The Motley Fool (writing Nov. 16, 2025), three names stand out for their strong moats, growth drivers, and resilience. 1. AMZN (Amazon): From household‑use to cloud computing dominance, Amazon benefits from multiple protective advantages: a vast e‑commerce ecosystem, a large logistics infrastructure and the high switching‑cost business of AWS. The article cites global e‑commerce expansion and potential satellite‑internet ventures as additional growth paths. 2. ENB (Enbridge): At first glance a pipeline utility — but look closer and you’ll see its tie‑in to AI infrastructure: transporting roughly one‑fifth of U.S. natural gas, which fuels data‑centres powering AI workloads. Add to that a 30‑year dividend growth streak and the appeal grows. 3. VRTX (Vertex Pharmaceuticals): Offers a “defensive and offensive” mix: on the defence, it markets the only approved therapies for cystic‑fibrosis — immune to major macro swings; on the offence, its gene‑editing and pain‑med breakthroughs have blockbuster potential. The article calls this one “well‑positioned to withstand a downturn and grow.” In short: whether you want bold growth (Amazon), steady income plus thematic utility (Enbridge), or biotech innovation with resilience (Vertex) — this trio ticks distinct boxes. That said, as the author notes, these picks aren’t a substitute for doing your own due‑diligence: valuation, timing, and diversification still matter. #StockPicking #InvestingToday #DividendGrowth #BiotechInnovation #SlimScan #GrowthStocks #CANSLIM